XML 31 R5.htm IDEA: XBRL DOCUMENT v3.25.2
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Class A Common Stock
Class B Common Stock
Total Stockholders’ Equity Attributable to Semrush Holdings, Inc.
Common Stock
Class A Common Stock
Common Stock
Class B Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Noncontrolling Interest
Redeemable Noncontrolling Interest, Beginning balance at Dec. 31, 2023 $ 0                  
Redeemable Noncontrolling Interest, Ending balance at Mar. 31, 2024 0                  
Beginning balance (in shares) at Dec. 31, 2023         120,629,147 23,482,057        
Beginning balance at Dec. 31, 2023 224,315     $ 219,149 $ 1 $ 0 $ 291,898 $ (752) $ (71,998) $ 5,166
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Issuance of common stock upon exercise of stock options (in shares)         469,879          
Issuance of common stock upon exercise of stock options 844     844     844      
Issuance of common stock upon vesting of restricted stock units (in shares)         145,844          
Stock-based compensation expense 5,115     5,115     5,115      
Cumulative translation adjustment (485)     (485)       (485)    
Unrealized gain (loss) on investments (744)     (744)       (744)    
Net income (loss) 2,138     2,138         2,138  
Net loss attributable to noncontrolling interest (135)                 (135)
Ending balance (in shares) at Mar. 31, 2024         121,244,870 23,482,057        
Ending balance at Mar. 31, 2024 231,048     226,017 $ 1 $ 0 297,857 (1,981) (69,860) 5,031
Redeemable Noncontrolling Interest, Beginning balance at Dec. 31, 2023 0                  
Redeemable Noncontrolling Interest, Ending balance at Jun. 30, 2024 8,733                  
Beginning balance (in shares) at Dec. 31, 2023         120,629,147 23,482,057        
Beginning balance at Dec. 31, 2023 224,315     219,149 $ 1 $ 0 291,898 (752) (71,998) 5,166
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Cumulative translation adjustment (604)                  
Unrealized gain (loss) on investments (928)                  
Net income (loss) 3,797                  
Ending balance (in shares) at Jun. 30, 2024         123,061,442 23,072,256        
Ending balance at Jun. 30, 2024 240,422     235,619 $ 1 $ 0 306,103 (2,284) (68,201) 4,803
Redeemable Noncontrolling Interest, Beginning balance at Mar. 31, 2024 0                  
Increase (Decrease) in Temporary Equity [Roll Forward]                    
Acquisition of redeemable noncontrolling interest (See Note 9) 9,846                  
Net loss attributable to redeemable noncontrolling interest (70)                  
Reclassification for Tender Offer obligations (See Note 9) (2,021)                  
Recording of redeemable noncontrolling interest at redemption value (See Note 9) 978                  
Redeemable Noncontrolling Interest, Ending balance at Jun. 30, 2024 8,733                  
Beginning balance (in shares) at Mar. 31, 2024         121,244,870 23,482,057        
Beginning balance at Mar. 31, 2024 231,048     226,017 $ 1 $ 0 297,857 (1,981) (69,860) 5,031
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Conversion of Class B Common Stock to Class A Common Stock (in shares)         409,801 409,801        
Issuance of common stock upon exercise of stock options (in shares)         720,880          
Issuance of common stock upon exercise of stock options 2,209     2,209     2,209      
Issuance of common stock upon vesting of restricted stock units (in shares)         685,891          
Stock-based compensation expense 7,015     7,015     7,015      
Cumulative translation adjustment (119)     (119)       (119)    
Unrealized gain (loss) on investments (184)     (184)       (184)    
Net income (loss) 1,659     1,659         1,659  
Net loss attributable to noncontrolling interest (228)                 (228)
Recording of redeemable noncontrolling interest at redemption value (See Note 9) (978)     (978)     (978)      
Ending balance (in shares) at Jun. 30, 2024         123,061,442 23,072,256        
Ending balance at Jun. 30, 2024 240,422     235,619 $ 1 $ 0 306,103 (2,284) (68,201) 4,803
Beginning balance (in shares) at Dec. 31, 2024   125,834,000 21,009,000   125,833,872 21,009,210        
Beginning balance at Dec. 31, 2024 266,352     256,604 $ 1 $ 0 322,586 (2,221) (63,762) 9,748
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Conversion of Class B Common Stock to Class A Common Stock (in shares)         100,800 100,800        
Issuance of common stock upon exercise of stock options (in shares)         52,666 111,408        
Issuance of common stock upon exercise of stock options 365     365     365      
Issuance of common stock upon vesting of restricted stock units (in shares)         643,823          
Stock-based compensation expense 8,966     8,966     8,966      
Cumulative translation adjustment 1,320     1,320       1,320    
Unrealized gain (loss) on investments 590     590       590    
Net income (loss) 849     849         849  
Net loss attributable to noncontrolling interest (194)                 (194)
Acquisition of additional noncontrolling shares (90)                 (90)
Ending balance (in shares) at Mar. 31, 2025         126,631,161 21,019,818        
Ending balance at Mar. 31, 2025 278,158     268,694 $ 1 $ 0 331,917 (311) (62,913) 9,464
Beginning balance (in shares) at Dec. 31, 2024   125,834,000 21,009,000   125,833,872 21,009,210        
Beginning balance at Dec. 31, 2024 266,352     256,604 $ 1 $ 0 322,586 (2,221) (63,762) 9,748
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Conversion of Class B Common Stock to Class A Common Stock (in shares)         100,800          
Cumulative translation adjustment 4,370                  
Unrealized gain (loss) on investments 713                  
Net income (loss) (5,718)                  
Ending balance (in shares) at Jun. 30, 2025   127,472,000 21,020,000   127,472,329 21,019,818        
Ending balance at Jun. 30, 2025 288,167     279,047 $ 1 $ 0 345,664 2,862 (69,480) 9,120
Beginning balance (in shares) at Mar. 31, 2025         126,631,161 21,019,818        
Beginning balance at Mar. 31, 2025 278,158     268,694 $ 1 $ 0 331,917 (311) (62,913) 9,464
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Conversion of Class B Common Stock to Class A Common Stock (in shares)         0          
Issuance of common stock upon exercise of stock options (in shares)         114,295          
Issuance of common stock upon exercise of stock options 283     283     283      
Issuance of common stock upon vesting of restricted stock units (in shares)         726,873          
Issuance of common stock upon vesting of restricted stock units (426)     (426)     (426)      
Stock-based compensation expense 13,342     13,342     13,342      
Reclassification of liability-classified awards to equity-classified awards 548     548     548      
Cumulative translation adjustment 3,050     3,050       3,050    
Unrealized gain (loss) on investments 123     123       123    
Net income (loss) (6,567)     (6,567)         (6,567)  
Net loss attributable to noncontrolling interest (210)                 (210)
Acquisition of additional noncontrolling shares (134)                 (134)
Ending balance (in shares) at Jun. 30, 2025   127,472,000 21,020,000   127,472,329 21,019,818        
Ending balance at Jun. 30, 2025 $ 288,167     $ 279,047 $ 1 $ 0 $ 345,664 $ 2,862 $ (69,480) $ 9,120